Sign in

CIK 0001430306

  • Non-accelerated filer
  • Smaller reporting company

Tonix Pharmaceuticals Holding Corp.

Sign in to watch
Ticker
TNXP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
261434750
Phone
+1 212-980-9155
Business address
200 CONNELL DRIVE, SUITE 3100, BERKELEY HEIGHTS, NJ, 07922
Former names
TAMANDARE EXPLORATIONS INC.
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 5 Insider Annual Insider Trading Report
  4. 5 Insider Annual Insider Trading Report
  5. 5 Insider Annual Insider Trading Report
  6. 4 Open-market buy Director bought 120,000 shares at $0.41 ($48,600)
  7. 4 Open-market buy Chief Executive Officer bought 98,000 shares at $0.43 ($41,924)
  8. 4 Open-market buy Chief Executive Officer bought 10,000 shares
  9. 4 Open-market buy Director bought 25,000 shares
  10. 4 Open-market buy Director bought 100,000 shares
  11. 4 Open-market buy Director bought 100,000 shares at $0.79 ($79,180)
  12. 4/A Open-market buy Director bought 12,500 shares at $2.00 ($25,000)
  13. 4 Open-market buy Chief Executive Officer bought 20,000 shares at $2.08 ($41,500)
  14. 4 Open-market buy Chief Financial Officer bought 2,000 shares at $2.00 ($4,000)
  15. 4 Open-market buy Director bought 25,000 shares at $2.00 ($50,000)
  16. 4 Open-market buy Director bought 50,000 shares at $2.00 ($100,000)
  17. 4 Open-market buy Chief Executive Officer bought 25,000 shares at $2.00 ($50,000)
  18. 4 Open-market buy Director bought 25,000 shares at $2.00 ($50,000)
  19. 4 Open-market buy DAUGHERTY BRUCE bought 100,000 shares at $2.00 ($200,000)
  20. 4 Open-market buy Chief Medical Officer bought 20,000 shares at $2.50 ($49,916)

Page 11 of 19 · 376 filings